MannKind caps off record year with Q4 earnings beat
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Inogen closes out rough year with decreasing revenue
Goleta-based Inogen saw shares dip nearly 20% in after-hours trading Feb. 27 after the company missed analyst expectations in the fourth quarter and had an overall rough year in fiscal year 2023. Inogen, a maker of portable oxygen containers, announced on Feb. 23 after the markets closed that fourth quarter total revenue was $75.9 million, down Read More →
SCE agrees to $80M payout over Thomas Fire lawsuit
Southern California Edison will be paying the United States $80 million on behalf of the U.S. Forest Service to recoup costs and damages associated with the 2017 Thomas Fire in the Los Padres National Forest that affected both Ventura and Santa Barbara counties. The settlement was finalized on Feb. 23 and announced by the U.S. Read More →
Undocumented immigrants make key contributions to state’s economy
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Updated: Thousand Oaks biotech firm emerges from stealth with $135M in funding
Editor’s note: This story was updated on Feb. 23 to include more info about the company’s lead treatment. Latigo Biotherapeutics, a Thousand Oaks-based biotech firm that was originally founded by Westlake Village BioPartners, emerged from stealth mode on Feb. 14, announcing $135 million in Series A financing. Latigo is a clinical-stage biotechnology company looking to Read More →